amphetamine 5 MG 24HR Extended Release Oral Tablet

RxCUI: 2585473
RxNorm name: amphetamine 5 MG 24HR Extended Release Oral Tablet
Display name: amphetamine 5 MG 24HR Extended Release Oral Tablet
Full name: amphetamine 5 MG 24HR Extended Release Oral Tablet
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:15

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Dyanavel XR	AMPHETAMINE	NextWave Pharmaceuticals, Inc	ae304b29-0b40-40ec-ad0d-76b742d4a9b9	2026-02-24	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2585473

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
ae304b29-0b40-40ec-ad0d-76b742d4a9b9	amphetamine 5 MG 24HR Extended Release Oral Tablet	PSN	14	These highlights do not include all the information needed to use DYANAVEL ® XR safely and effectively. See full prescribing information for DYANAVEL XR . DYANAVEL ® XR (amphetamine) extended-release oral suspension , CII DYANAVEL ® XR (amphetamine) extended-release tablets, for oral use, CII Initial U.S. Approval: 1 960	20260224
ae304b29-0b40-40ec-ad0d-76b742d4a9b9	24 HR amphetamine 5 MG Extended Release Oral Tablet	SCD	14	These highlights do not include all the information needed to use DYANAVEL ® XR safely and effectively. See full prescribing information for DYANAVEL XR . DYANAVEL ® XR (amphetamine) extended-release oral suspension , CII DYANAVEL ® XR (amphetamine) extended-release tablets, for oral use, CII Initial U.S. Approval: 1 960	20260224